Leadingtac Pharmaceutical (Shaoxing) Co., Ltd.
4 clinical trials · Sponsor
◉ Watch Leadingtac Pharmaceutical (Shaoxing) Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| Study of LT-010391 in Participants With KRAS G12D-Mutant Solid Tumors (NCT07624214) | Leadingtac Pharmaceutical (Shaoxing) Co., Ltd. | 2026-07-01 |
| A Study to Explore the Safety, Tolerability, Efficacy, and Pharmacokinetics of LT-002-158 Tablets in Chinese Adult Patients With Hidradenitis Suppurativa (NCT06932003) | Leadingtac Pharmaceutical (Shaoxing) Co., Ltd. | 2025-04-15 |
| A Study to Explore the Safety, Tolerability, Efficacy, and Pharmacokinetics of LT-002-158 Tablets in Chinese Adult Subjects With Atopic Dermatitis (NCT06931990) | Leadingtac Pharmaceutical (Shaoxing) Co., Ltd. | 2025-04-15 |
| A Single and Multiple Ascending Dose Trial of LT-002-158 Tablets in Healthy Adult Volunteers (NCT06082323) | Leadingtac Pharmaceutical (Shaoxing) Co., Ltd. | 2024-06-13 |
Track Leadingtac Pharmaceutical (Shaoxing) Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.